Allison Gamboa Hays
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Allison Gamboa Hays has a total of 425 co-authors. Here are the top co-authors by number of shared publications:
- Anum S. Minhas
Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
20 shared publications - Erin Donelly Michos
Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, USA
17 shared publications - Michael Schär
Division of Magnetic Resonance Research, Department of Radiology, Johns Hopkins University School of Medicine , Baltimore, MD
13 shared publications - Gary Gerstenblith
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD
10 shared publications Anum S. Minhas
Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
9 shared publicationsErin Goerlich
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
9 shared publications
Latest Publications
- 4 September 2026
- Published by Springer Nature in Current Hypertension Reports
- Vol. 28 (1) , 37
Indigenous Health Disparities in Hypertensive Disorders of Pregnancy Within the United States
- 4 September 2026
- Published by Springer Nature in Current Hypertension Reports
- Vol. 28 (1) , 37
Indigenous Health Disparities in Hypertensive Disorders of Pregnancy Within the United States
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (9)
Coronary Inflammation Is Associated With Plaque Progression in Men With HIV
BACKGROUND: People with HIV are at elevated risk for atherosclerotic cardiovascular disease despite viral suppression, suggesting contributions from nontraditional mechanisms. Coronary vascular inflammation may play a role, but its relationship to plaque progression remains incompletely defined. The perivascular fat attenuation index (FAI) score, derived from coronary computed tomography angiography, is associated with vascular inflammation. We evaluated whether coronary inflammation is associated with the incidence and progression of coronary plaque and whether these relationships differ by HIV status. METHODS: A total of 504 men (n=292 with HIV; n=212 without HIV) from the Multicenter AIDS Cohort Study underwent coronary computed tomography angiography over a median of 4.5 years (3.8–4.9). FAI measurements were performed on baseline scans. Changes in noncalcified, calcified, and total plaque volumes were categorized into tertiles of progression. Associations were estimated using multinomial logistic regression adjusted for interscan time and cardiovascular risk factors. Modified Poisson regression estimated incident plaque. RESULTS: Higher FAI scores in the left anterior descending (LAD) and left circumflex were associated with greater odds of belonging to the highest tertile of noncalcified (LAD odds ratio [OR], 1.83 [1.27–2.64]; left circumflex OR, 2.55 [1.66–3.91]); calcified (LAD OR, 2.62 [1.64–4.18]; left circumflex OR, 3.92 [2.36–6.51]); and total plaque progression (LAD OR, 1.81 [1.25–2.62]; left circumflex OR, 2.65 [1.71–4.10]) among men with HIV, per SD increase in FAI score after adjusting for cardiovascular risk factors, and remained significant after adjustment for baseline plaque. Higher LAD FAI score was associated with incident calcified plaque in men with HIV (RR, 1.21 [1.01–1.46]). Associations for noncalcified and calcified plaque progression were stronger in men with HIV than in men without HIV. CONCLUSIONS: Coronary inflammation, assessed by FAI, is independently associated with incident and progressive coronary plaque in men with HIV. These findings support a role for vascular inflammation in accelerated atherosclerosis in people with HIV and highlight FAI as a potential biomarker for risk stratification.
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (9)
Open AccessCoronary Inflammation Is Associated With Plaque Progression in Men With HIV
BACKGROUND: People with HIV are at elevated risk for atherosclerotic cardiovascular disease despite viral suppression, suggesting contributions from nontraditional mechanisms. Coronary vascular inflammation may play a role, but its relationship to plaque progression remains incompletely defined. The perivascular fat attenuation index (FAI) score, derived from coronary computed tomography angiography, is associated with vascular inflammation. We evaluated whether coronary inflammation is associated with the incidence and progression of coronary plaque and whether these relationships differ by HIV status. METHODS: A total of 504 men (n=292 with HIV; n=212 without HIV) from the Multicenter AIDS Cohort Study underwent coronary computed tomography angiography over a median of 4.5 years (3.8–4.9). FAI measurements were performed on baseline scans. Changes in noncalcified, calcified, and total plaque volumes were categorized into tertiles of progression. Associations were estimated using multinomial logistic regression adjusted for interscan time and cardiovascular risk factors. Modified Poisson regression estimated incident plaque. RESULTS: Higher FAI scores in the left anterior descending (LAD) and left circumflex were associated with greater odds of belonging to the highest tertile of noncalcified (LAD odds ratio [OR], 1.83 [1.27–2.64]; left circumflex OR, 2.55 [1.66–3.91]); calcified (LAD OR, 2.62 [1.64–4.18]; left circumflex OR, 3.92 [2.36–6.51]); and total plaque progression (LAD OR, 1.81 [1.25–2.62]; left circumflex OR, 2.65 [1.71–4.10]) among men with HIV, per SD increase in FAI score after adjusting for cardiovascular risk factors, and remained significant after adjustment for baseline plaque. Higher LAD FAI score was associated with incident calcified plaque in men with HIV (RR, 1.21 [1.01–1.46]). Associations for noncalcified and calcified plaque progression were stronger in men with HIV than in men without HIV. CONCLUSIONS: Coronary inflammation, assessed by FAI, is independently associated with incident and progressive coronary plaque in men with HIV. These findings support a role for vascular inflammation in accelerated atherosclerosis in people with HIV and highlight FAI as a potential biomarker for risk stratification.
- 8 August 2026
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 19 (1) , 6
Mapping Myocarditis: Transatlantic Perspectives on Myocarditis Diagnostic Frameworks Across Europe and the United States
- 8 August 2026
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 19 (1) , 6
Mapping Myocarditis: Transatlantic Perspectives on Myocarditis Diagnostic Frameworks Across Europe and the United States
- Open Access
- 17 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102803
Maternal Mortality and Cardio-Kidney-Metabolic Risk Factors Across High-Income Countries
- 17 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102803
Open AccessMaternal Mortality and Cardio-Kidney-Metabolic Risk Factors Across High-Income Countries
- 16 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (2) , H490-H497
Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
People with HIV (PWH) remain at increased risk for cardiovascular disease despite sustained viral suppression on antiretroviral therapy, but the biological mechanisms underlying this risk are incompletely understood. We hypothesized that coronary endothelial dysfunction in virally suppressed PWH is associated with specific circulating proteomic signatures reflecting metabolic and redox pathway dysregulation. We conducted a prospective observational study integrating in vivo stress cardiovascular magnetic resonance imaging with high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary magnetic resonance imaging during isometric handgrip exercise to quantify coronary endothelial function, defined as the percent change in coronary cross-sectional area from rest to stress, with an increase <2% indicating endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression was analyzed using linear modeling. Coronary endothelial dysfunction was significantly more prevalent among PWH than controls (67% vs 10%, p<0.001). Pathway enrichment analysis of differentially expressed proteins between participants with and without endothelial dysfunction identified significant dysregulation of glutathione-dependent detoxification, oxidative metabolism, and fatty acid β-oxidation pathways (adjusted p<0.05). However, despite the higher prevalence of coronary endothelial dysfunction among PWH compared with controls without HIV, we did not identify a distinct baseline clinical or proteomic profile that fully explained this difference. These findings demonstrate that coronary endothelial dysfunction in virally suppressed PWH is associated with metabolic and redox imbalance, identifying glutathione and fatty acid oxidation pathways as potential therapeutic targets to mitigate residual cardiovascular risk in this population.
- 16 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (2) , H490-H497
Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
People with HIV (PWH) remain at increased risk for cardiovascular disease despite sustained viral suppression on antiretroviral therapy, but the biological mechanisms underlying this risk are incompletely understood. We hypothesized that coronary endothelial dysfunction in virally suppressed PWH is associated with specific circulating proteomic signatures reflecting metabolic and redox pathway dysregulation. We conducted a prospective observational study integrating in vivo stress cardiovascular magnetic resonance imaging with high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary magnetic resonance imaging during isometric handgrip exercise to quantify coronary endothelial function, defined as the percent change in coronary cross-sectional area from rest to stress, with an increase <2% indicating endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression was analyzed using linear modeling. Coronary endothelial dysfunction was significantly more prevalent among PWH than controls (67% vs 10%, p<0.001). Pathway enrichment analysis of differentially expressed proteins between participants with and without endothelial dysfunction identified significant dysregulation of glutathione-dependent detoxification, oxidative metabolism, and fatty acid β-oxidation pathways (adjusted p<0.05). However, despite the higher prevalence of coronary endothelial dysfunction among PWH compared with controls without HIV, we did not identify a distinct baseline clinical or proteomic profile that fully explained this difference. These findings demonstrate that coronary endothelial dysfunction in virally suppressed PWH is associated with metabolic and redox imbalance, identifying glutathione and fatty acid oxidation pathways as potential therapeutic targets to mitigate residual cardiovascular risk in this population.
- 1 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (6) , e26760
Stress and Coronary Vascular Dysfunction in Women With Prior Preeclampsia
- 1 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (6) , e26760
Stress and Coronary Vascular Dysfunction in Women With Prior Preeclampsia
- 26 May 2026
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 28 (1)
Beyond the Coronaries: Utility of Extra-Coronary Calcification for Cardiovascular Risk Assessment in Women
Globally, cardiovascular disease (CVD) is the leading cause of mortality in women. Traditional risk calculators underestimate atherosclerotic cardiovascular disease risk (ASCVD), particularly in women classified as low or intermediate risk. While coronary artery calcium scoring improves risk stratification, it remains underutilized in practice. Extra-coronary calcification (ECC), including breast arterial calcification, valvular calcification, and thoracic aortic calcification have emerged as promising adjunctive imaging biomarkers for cardiovascular risk assessment in women. The processes of vascular and valvular calcification are influenced by inflammation, osteogenic signaling pathways, and sex hormones. Unique female factors, such as the menopausal transition, parity, and pregnancy-related complications, further influence calcification. The incidental ECC detection that is possible through screening mammography, echocardiography, and chest computed tomography offers an opportunity for cardiovascular risk identification without additional cost or radiation. Evidence has suggested ECC to be independently associated with coronary artery disease, stroke, heart failure, atrial fibrillation, and cardiovascular mortality. Further, studies have shown links between ECC with higher cardiovascular risk, particularly among women whose risk may be underestimated by traditional tools. In women, ECC may be valuable as a complementary ASCVD risk-enhancing marker, serving to augment and expedite preventive care. Heterogeneity in ECC recognition, a lack of standardized scoring, and limited prospective outcome data have prevented the integration of ECC metrics into cardiovascular guidelines to date. Future efforts should prioritize standardized reporting, artificial intelligence-assisted quantification, and well-designed prospective trials to determine whether ECC-guided prevention might improve cardiovascular outcomes in women.
- 26 May 2026
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 28 (1)
Beyond the Coronaries: Utility of Extra-Coronary Calcification for Cardiovascular Risk Assessment in Women
Globally, cardiovascular disease (CVD) is the leading cause of mortality in women. Traditional risk calculators underestimate atherosclerotic cardiovascular disease risk (ASCVD), particularly in women classified as low or intermediate risk. While coronary artery calcium scoring improves risk stratification, it remains underutilized in practice. Extra-coronary calcification (ECC), including breast arterial calcification, valvular calcification, and thoracic aortic calcification have emerged as promising adjunctive imaging biomarkers for cardiovascular risk assessment in women. The processes of vascular and valvular calcification are influenced by inflammation, osteogenic signaling pathways, and sex hormones. Unique female factors, such as the menopausal transition, parity, and pregnancy-related complications, further influence calcification. The incidental ECC detection that is possible through screening mammography, echocardiography, and chest computed tomography offers an opportunity for cardiovascular risk identification without additional cost or radiation. Evidence has suggested ECC to be independently associated with coronary artery disease, stroke, heart failure, atrial fibrillation, and cardiovascular mortality. Further, studies have shown links between ECC with higher cardiovascular risk, particularly among women whose risk may be underestimated by traditional tools. In women, ECC may be valuable as a complementary ASCVD risk-enhancing marker, serving to augment and expedite preventive care. Heterogeneity in ECC recognition, a lack of standardized scoring, and limited prospective outcome data have prevented the integration of ECC metrics into cardiovascular guidelines to date. Future efforts should prioritize standardized reporting, artificial intelligence-assisted quantification, and well-designed prospective trials to determine whether ECC-guided prevention might improve cardiovascular outcomes in women.
- Open Access
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e047908
Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure
Background: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. Methods: The study included 6025 participants in MESA (Multi‐Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002–2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010–2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. Results: Over a mean follow‐up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22–1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27–1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11–1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03–0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16–1.41]). Conclusions: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e047908
Open AccessGlucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure
Background: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. Methods: The study included 6025 participants in MESA (Multi‐Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002–2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010–2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. Results: Over a mean follow‐up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22–1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27–1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11–1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03–0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16–1.41]). Conclusions: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.
- Open Access
- 17 March 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (1) , 13-26
Simultaneous Assessment of Skeletal Muscle Energetics and Blood Flow During Dynamic Exercise by Interleaved 31 P ‐ MRS / 1 H ‐ MRI
Purpose: To simultaneously measure skeletal muscle energetics and blood flow (BF) before, during, and after dynamic plantar flexion exercise (PFE). Methods: Non‐localized pulse‐acquire phosphorus‐31 magnetic resonance spectroscopy ( 31 P MRS) and phase contrast flow magnetic resonance imaging ( 1 H MRI) using golden‐angle rotated spiral readouts were acquired in an interleaved fashion. Data were collected at rest, during PFE to volitional fatigue, and post‐exercise recovery in 10 healthy adults. Interleaved popliteal artery BF was validated against conventional cine phase‐contrast measures at rest and post‐exercise recovery, while calf muscle energetics were validated by comparing to conventional 31 P MRS‐only measures at rest. To minimize motion artifacts during dynamic PFE, flow data were resolved in 3 dimensions (cardiac phase, pedal position, and exercise stage). Results: Resting phosphocreatine (PCr) and inorganic phosphate concentrations were similar between both techniques (both p > 0.05). During PFE, PCr declined to 46% ± 10% of rest. PCr recovery time was 43 ± 15 s. Resting BF was 132 ± 43 mL/min and increased up to four‐fold during PFE depending on exercise stage and pedal position. Notably, there was excellent agreement between the interleaved and conventional BF measures ( r 2 = 0.95, slope = 0.977, p < 0.0001) with minimal bias (12.62 mL/min) over a wide range of physiologically relevant BF values (from ∼60 to 600 mL/min). Conclusion: The feasibility of simultaneous assessment of skeletal muscle energetics and BF during dynamic exercise by interleaved 31 P MRS/ 1 H flow MRI was demonstrated along with good agreement between interleaved and conventional techniques during rest and recovery. One can now simultaneously quantify critical BF‐metabolism relationships and use this to probe disease‐related adaptations.
- 17 March 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (1) , 13-26
Open AccessSimultaneous Assessment of Skeletal Muscle Energetics and Blood Flow During Dynamic Exercise by Interleaved 31 P ‐ MRS / 1 H ‐ MRI
Purpose: To simultaneously measure skeletal muscle energetics and blood flow (BF) before, during, and after dynamic plantar flexion exercise (PFE). Methods: Non‐localized pulse‐acquire phosphorus‐31 magnetic resonance spectroscopy ( 31 P MRS) and phase contrast flow magnetic resonance imaging ( 1 H MRI) using golden‐angle rotated spiral readouts were acquired in an interleaved fashion. Data were collected at rest, during PFE to volitional fatigue, and post‐exercise recovery in 10 healthy adults. Interleaved popliteal artery BF was validated against conventional cine phase‐contrast measures at rest and post‐exercise recovery, while calf muscle energetics were validated by comparing to conventional 31 P MRS‐only measures at rest. To minimize motion artifacts during dynamic PFE, flow data were resolved in 3 dimensions (cardiac phase, pedal position, and exercise stage). Results: Resting phosphocreatine (PCr) and inorganic phosphate concentrations were similar between both techniques (both p > 0.05). During PFE, PCr declined to 46% ± 10% of rest. PCr recovery time was 43 ± 15 s. Resting BF was 132 ± 43 mL/min and increased up to four‐fold during PFE depending on exercise stage and pedal position. Notably, there was excellent agreement between the interleaved and conventional BF measures ( r 2 = 0.95, slope = 0.977, p < 0.0001) with minimal bias (12.62 mL/min) over a wide range of physiologically relevant BF values (from ∼60 to 600 mL/min). Conclusion: The feasibility of simultaneous assessment of skeletal muscle energetics and BF during dynamic exercise by interleaved 31 P MRS/ 1 H flow MRI was demonstrated along with good agreement between interleaved and conventional techniques during rest and recovery. One can now simultaneously quantify critical BF‐metabolism relationships and use this to probe disease‐related adaptations.
- Top Cited Papers
- 17 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (7) , 480-492
Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women
BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among younger women in the United States. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains unclear whether HDP independently increase CVD risk or reflect poor prepregnancy health. We aimed to quantify the association between HDP and incident CVD in a diverse, real-world population, with replication of findings across health systems. METHODS: We used data from the All of Us research program, encompassing >50 health systems across the United States, to identify women with longitudinal pregnancy and postpartum data (n=17 357; between 2007 and 2022). Multivariable Cox regression estimated adjusted hazard ratios (aHRs) of HDP with CVD (ischemic heart disease, heart failure, or stroke), overall and stratified by prepregnancy cardiometabolic risk factors (hypertension, obesity, diabetes, hyperlipidemia, or chronic kidney disease). Analyses were replicated in an independent health system (n=56 549; between 2016 and 2025) using the Observational Medical Outcomes Partnership Common Data Model. RESULTS: Participants had a median [interquartile range] age of 30 [25, 35] years; 2719 (16%) identified as Black or African American, and 7267 (42%) identified as Hispanic or Latino. Among those who reported socioeconomic data, 4306 (35%) reported an income <$25 000, and 6429 (37%) a high school education at most. HDP occurred in 2098 (12%) of pregnancies. Over a median of 4.6 years of follow-up, 701 women developed CVD. Overall, HDP were associated with elevated CVD risk (aHR, 1.82 [95% CI, 1.49–2.22]). Regardless of prepregnancy cardiometabolic risk factors, HDP were independently associated with CVD risk (aHR, 2.06 [95% CI, 1.55–2.74] among women without risk factors, and aHR, 1.33 [95% CI, 1.00–1.77] among women with risk factors). Main findings showed similar effect estimates for the risk of HDP with composite CVD (aHR, 2.62 [95% CI, 2.17–3.16]) in the external replication cohort. CONCLUSIONS: In a diverse, national sample of young US women, HDP were a significant marker of premature CVD risk, even in the absence of prepregnancy cardiometabolic risk factors. Integrating pregnancy complications into CVD risk stratification and promoting cardiometabolic health before, during, and after pregnancy may reduce the growing burden of early-onset CVD among women.
- 17 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (7) , 480-492
Top Cited PapersHypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women
BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among younger women in the United States. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains unclear whether HDP independently increase CVD risk or reflect poor prepregnancy health. We aimed to quantify the association between HDP and incident CVD in a diverse, real-world population, with replication of findings across health systems. METHODS: We used data from the All of Us research program, encompassing >50 health systems across the United States, to identify women with longitudinal pregnancy and postpartum data (n=17 357; between 2007 and 2022). Multivariable Cox regression estimated adjusted hazard ratios (aHRs) of HDP with CVD (ischemic heart disease, heart failure, or stroke), overall and stratified by prepregnancy cardiometabolic risk factors (hypertension, obesity, diabetes, hyperlipidemia, or chronic kidney disease). Analyses were replicated in an independent health system (n=56 549; between 2016 and 2025) using the Observational Medical Outcomes Partnership Common Data Model. RESULTS: Participants had a median [interquartile range] age of 30 [25, 35] years; 2719 (16%) identified as Black or African American, and 7267 (42%) identified as Hispanic or Latino. Among those who reported socioeconomic data, 4306 (35%) reported an income <$25 000, and 6429 (37%) a high school education at most. HDP occurred in 2098 (12%) of pregnancies. Over a median of 4.6 years of follow-up, 701 women developed CVD. Overall, HDP were associated with elevated CVD risk (aHR, 1.82 [95% CI, 1.49–2.22]). Regardless of prepregnancy cardiometabolic risk factors, HDP were independently associated with CVD risk (aHR, 2.06 [95% CI, 1.55–2.74] among women without risk factors, and aHR, 1.33 [95% CI, 1.00–1.77] among women with risk factors). Main findings showed similar effect estimates for the risk of HDP with composite CVD (aHR, 2.62 [95% CI, 2.17–3.16]) in the external replication cohort. CONCLUSIONS: In a diverse, national sample of young US women, HDP were a significant marker of premature CVD risk, even in the absence of prepregnancy cardiometabolic risk factors. Integrating pregnancy complications into CVD risk stratification and promoting cardiometabolic health before, during, and after pregnancy may reduce the growing burden of early-onset CVD among women.